Your session is about to expire
← Back to Search
App-Based Reading and Screen Time Guidance for Parent-Child Relationship
N/A
Waitlist Available
Led By John Hutton, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between 6- and 12-month visits compared between groups.
Awards & highlights
No Placebo-Only Group
Summary
This trial uses special books and videos through an app to help parents read to their babies and limit screen time. It targets low-income families who may not have much experience with reading to their children. The program makes reading fun and engaging, which helps babies' brain development and reduces screen time.
Who is the study for?
This trial is for parents with infants under 2.5 months old who speak English fluently and own a smartphone compatible with the Reading Bees app. It's not for those whose children have certain health conditions like extreme prematurity or risk of language delays.
What is being tested?
The study tests an app-based program, Reading Bees, which guides parents on reading to their infants and managing screen time. The intervention includes using the app along with specially designed books during pediatric visits.
What are the potential side effects?
There are no direct medical side effects since this trial involves educational guidance rather than medication. However, there may be indirect effects on family routines or infant behavior as new practices are introduced.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between 6- and 12-month visits compared between groups.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between 6- and 12-month visits compared between groups.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Efficacy - change in qualitative home reading behaviors
Efficacy - change in quantitative home reading behaviors
Efficacy - digital media use (screen time)
+3 moreSecondary study objectives
Video Observation of Shared Reading - Change in Parent-Child Bonding
Video Observation of Shared Reading - Reading Quality
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
These parents will have a new mobile app (Reading Bees) installed onto their smartphone during a baseline clinic visit between 0 and 2-months old. They will also receive a specially designed children's book modeling the SHARE/STEP approach to reading with infants.
At 6-months, these parents will also receive guidance regarding limiting digital media use (screen time) using content in the app and a specially designed children's book.
They will also receive usual guidance during clinic visits via the Reach Out and Read program
Group II: ControlActive Control1 Intervention
These parents will receive usual reading and screen time guidance during pediatric clinic visits, including via the Reach Out and Read program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reading Bees app and children's book to enhance parent-infant reading quality (0-2 month visit)
2022
N/A
~160
Reading Bees app and children's book to encourage alternatives to digital media (6-month visit)
2022
N/A
~160
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The Reading Bees Mobile App intervention enhances literacy through educational materials that improve phonologic awareness and letter-sound relationships, and through guidance that promotes interactive shared reading. Limiting screen time reduces distractions, allowing children to focus on literacy activities.
These mechanisms are crucial as they foster early literacy skills, improve language development, and create a conducive learning environment, which are essential for the literacy development of young children.
Relative Effectiveness of Reading Intervention Programs for Adults with Low Literacy.Efficacy of learning strategies instruction in adult basic education.Efficacy of a Reading Intervention for Middle School Students Identified with Learning Disabilities.
Relative Effectiveness of Reading Intervention Programs for Adults with Low Literacy.Efficacy of learning strategies instruction in adult basic education.Efficacy of a Reading Intervention for Middle School Students Identified with Learning Disabilities.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,457 Total Patients Enrolled
2 Trials studying Literacy
396 Patients Enrolled for Literacy
John Hutton, MDPrincipal InvestigatorAssistant Professor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have no history of severe brain injury, was not extremely premature, or have conditions risking language delays.My child is younger than 2.5 months old.My child's primary caregiver is 18 years or older.My child and I are available for video observation as part of the study.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.